BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12708154)

  • 21. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Cardiol Clin; 2009 Feb; 27(1):125-35, ix. PubMed ID: 19111769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiology and etiology of atrial fibrillation].
    Mabo P; Pavin D; Leclercq C
    Rev Prat; 2002 Jun; 52(12):1295-300. PubMed ID: 12187891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical challenge of the atrial fibrillation].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological treatment of persistent atrial fibrillation in the older adult: evidence-based practice.
    Stanley JM
    J Am Acad Nurse Pract; 2011 Mar; 23(3):120-6. PubMed ID: 21355944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate versus rhythm control in the management of patients with atrial fibrillation.
    Pelargonio G; Prystowsky EN
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):514-21. PubMed ID: 16186849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation in the elderly.
    Wetzel U; Hindricks G; Piorkowski C
    Minerva Med; 2009 Apr; 100(2):145-50. PubMed ID: 19390500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation: rhythm control offers no advantage over rate control for some, but not all.
    Li YB; Hu CL; Liu J; Chen YX; Qu Z; Xu JL; Chen JB; Wan J; Tang QZ; Huang CX
    Med Hypotheses; 2007; 69(1):206-8. PubMed ID: 17011138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical management of atrial fibrillation.
    Alexander C; Flaker GC
    South Med J; 1999 Dec; 92(12):1136-43. PubMed ID: 10624902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Atrial fibrillation in elderly patients].
    Massoure PL; Sacher F; Derval N; Hocini M; Jais P; Haissaguerre M
    Rev Prat; 2009 Dec; 59(10):1365-9. PubMed ID: 20058755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate control versus rhythm control.
    Vidaillet H; Greenlee RT
    Curr Opin Cardiol; 2005 Jan; 20(1):15-20. PubMed ID: 15596954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
    Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.
    Go AS
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S58-65. PubMed ID: 15152747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
    J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of rhythm and rate control in patients with atrial fibrillation.
    Prystowsky EN
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S7-10. PubMed ID: 16939436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.